• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SOLTA MEDICAL INC. THERMAGE FLX (TG-3A) SYSTEM AND ACCESSORIES; ELECTROSURGICAL,CUTTING & COAGULATION & ACC.

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SOLTA MEDICAL INC. THERMAGE FLX (TG-3A) SYSTEM AND ACCESSORIES; ELECTROSURGICAL,CUTTING & COAGULATION & ACC. Back to Search Results
Model Number TT0.25F6-450
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Burn(s) (1757); Erythema (1840)
Event Date 10/02/2021
Event Type  Injury  
Manufacturer Narrative
Data-log of the treatment was evaluated.Evaluation of the data suggests that the handpiece and system performed as expected.Treatment tip has been requested for evaluation, but not yet received.A review of the device manufacturing record has been initiated but not yet completed.Based on currently available information no conclusion can be drawn and no cause has been established.
 
Event Description
The patient reported by phone that they experienced blistering on both eyes following a thermage flx eye treatment.The treatment details were collected from the treating clinic upon follow up.The doctor reported that prior to treatment they inspected the treatment tip with no observed abnormalities and the patient was administered an unknown topical anesthetic.The doctor reported the treatment was completed without any issue, ample coupling fluid was used, and the highest energy level was 2.5.The patient reported noticing blisters forming on the left eye lid immediately following treatment.The patient used cold compress over the eyes.The following day the patient noticed less severe blistering on the right eye as well and visited the local hospital for diagnosis.Patient was diagnosed with burn and prescribed an unidentified scald cream.Available pictures were reviewed by medical evaluator.Two small crusts are visible on the upper eyelid and two small post inflammatory hyperpigmented lesions are visible on the lower eyelid.Current patient status was reported as slight hyperpigmentation remaining.
 
Manufacturer Narrative
Treatment tip was returned to manufacturer and evaluated by technical team.The tip passed leak and thermistor testing, as well as visual inspection, with no observed abnormalities.No functional testing was performed due to the tip being expired.A review of the treatment data was previously completed, and showed the system and handpiece performed as expected during treatment.A review of the device manufacturing record has been initiated but not yet completed.Based on currently available information no conclusion can be drawn and no cause has been established.
 
Manufacturer Narrative
According to thermage flx system user manual burns are a known possible adverse patient reaction to thermage flx treatment.The procedure produces heating in the upper layers of the skin and may cause burns and subsequent blister and scab formation.There is a small chance of scar formation.Application of topical steroidal or antibiotic preparations may be of benefit.In the rare instance of a burn that results in a scar, the scar will probably be very small and respond readily to removal with a laser device.A review of the manufacturing records showed all requirements were met.Data logs confirmed the system and handpiece performed as expected.Evaluation of the treatment tip found no issues related to this event.This event is most likely unrelated to the device.Based on the available information, burns and blisters are a known possible side effects during thermage flx treatment.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERMAGE FLX (TG-3A) SYSTEM AND ACCESSORIES
Type of Device
ELECTROSURGICAL,CUTTING & COAGULATION & ACC.
Manufacturer (Section D)
SOLTA MEDICAL INC.
11720 north creek pkwy n
suite 100
bothell WA 98011
Manufacturer (Section G)
SOLTA MEDICAL INC
11720 n creek parkway n
suite 100
bothell WA 98011
Manufacturer Contact
jennifer gamet
1400 goodman st n
rochester, NY 14609
MDR Report Key12760906
MDR Text Key280474485
Report Number3011423170-2021-00124
Device Sequence Number1
Product Code GEI
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K132431
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Consumer,Health Professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date 10/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberTT0.25F6-450
Device Catalogue NumberTT0.25F6-450
Device Lot Number222
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/11/2021
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 10/08/2021
Initial Date FDA Received11/07/2021
Supplement Dates Manufacturer Received11/17/2021
03/11/2022
Supplement Dates FDA Received12/16/2021
04/10/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/31/2020
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexMale
-
-